239 related articles for article (PubMed ID: 22651131)
1. Editorial comment to association of prostate-specific antigen doubling time and cancer in men undergoing repeat prostate biopsy.
Shimbo M
Int J Urol; 2012 Aug; 19(8):747-8. PubMed ID: 22651131
[No Abstract] [Full Text] [Related]
2. Association of prostate-specific antigen doubling time and cancer in men undergoing repeat prostate biopsy.
Moreira DM; Gerber L; Thomas JA; Bañez LL; McKeever MG; Freedland SJ
Int J Urol; 2012 Aug; 19(8):741-7. PubMed ID: 22487442
[TBL] [Abstract][Full Text] [Related]
3. Editorial comment from Dr Urakami to impact of obesity on the predictive accuracy of prostate-specific antigen density and prostate-specific antigen in native Korean men undergoing prostate biopsy.
Urakami S
Int J Urol; 2014 Oct; 21(10):990-1. PubMed ID: 24909066
[No Abstract] [Full Text] [Related]
4. Editorial comment from Dr Simonato and Dr Romagnoli to impact of obesity on the predictive accuracy of prostate-specific antigen density and prostate-specific antigen in native Korean men undergoing prostate biopsy.
Simonato A; Romagnoli A
Int J Urol; 2014 Oct; 21(10):991. PubMed ID: 24931339
[No Abstract] [Full Text] [Related]
5. Editorial Comment to Importance of prostate volume in the stratification of patients with intermediate-risk prostate cancer.
Yashi M
Int J Urol; 2015 Jun; 22(6):561-2. PubMed ID: 25799888
[No Abstract] [Full Text] [Related]
6. Editorial comment on: decision-making about PSA testing and prostate biopsies: a qualitative study embedded in a primary care randomised trial.
Finney Rutten LJ
Eur Urol; 2008 Jun; 53(6):1193. PubMed ID: 17709172
[No Abstract] [Full Text] [Related]
7. Editorial comment.
Schilling D; Stenzl A
J Urol; 2010 Feb; 183(2):527-8; discussion 528. PubMed ID: 20006885
[No Abstract] [Full Text] [Related]
8. Editorial comment. Correlation between serum prostate-specific antigen and cancer volume in prostate glands of different sizes.
Autorino R; Perdonà S; Di Lorenzo G
Urology; 2010 Nov; 76(5):1076; author reply 1076-7. PubMed ID: 21056255
[No Abstract] [Full Text] [Related]
9. Editorial comment.
Ukimura O
J Urol; 2014 Dec; 192(6):1648; discussion 1649. PubMed ID: 25194546
[No Abstract] [Full Text] [Related]
10. Editorial comment.
Phillips J
J Urol; 2014 Dec; 192(6):1649; discussion 1649. PubMed ID: 25194544
[No Abstract] [Full Text] [Related]
11. Some concerns about prostate cancer location, Gleason grade, and postradiation doubling times.
Stamey TA
Int J Radiat Oncol Biol Phys; 1995 Nov; 33(4):967-8; discussion 972. PubMed ID: 7591913
[No Abstract] [Full Text] [Related]
12. Editorial comment: Critical role of prostate biopsy mortality in the number of years of life gained and lost within a prostate cancer screening programme.
Albertsen PC
BJU Int; 2012 Dec; 110(11):1653. PubMed ID: 22984891
[No Abstract] [Full Text] [Related]
13. Editorial comment on: Post-treatment prostate biopsies in the era of three-dimensional conformal radiotherapy: what can they teach us?
Stanislaus P; Seitz M
Eur Urol; 2009 Apr; 55(4):909-10. PubMed ID: 18485577
[No Abstract] [Full Text] [Related]
14. Utility of percent free prostate-specific antigen in repeat prostate biopsy.
Lee BH; Hernandez AV; Zaytoun O; Berglund RK; Gong MC; Jones JS
Urology; 2011 Aug; 78(2):386-91. PubMed ID: 21683989
[TBL] [Abstract][Full Text] [Related]
15. Editorial comment.
Epstein JI
J Urol; 2010 Mar; 183(3):1001. PubMed ID: 20089268
[No Abstract] [Full Text] [Related]
16. Editorial comment.
Vollmer RT
J Urol; 2010 Mar; 183(3):1001-2. PubMed ID: 20089267
[No Abstract] [Full Text] [Related]
17. Optimal predictors of prostate cancer on repeat prostate biopsy: a prospective study of 1,051 men.
Djavan B; Zlotta A; Remzi M; Ghawidel K; Basharkhah A; Schulman CC; Marberger M
J Urol; 2000 Apr; 163(4):1144-8; discussion 1148-9. PubMed ID: 10737484
[TBL] [Abstract][Full Text] [Related]
18. Editorial comment on: prostate-specific antigen kinetics in clinical decision-making during active surveillance for early prostate cancer--a review.
Rittmaster R
Eur Urol; 2008 Sep; 54(3):514-5. PubMed ID: 18585846
[No Abstract] [Full Text] [Related]
19. [Change in serum prostate specific antigen values in men who had no evidence of prostate cancer on initial biopsy].
Miyamoto S; Jimbo H; Totsuka Y; Mashimo T; Umeyama T; Uehara H; Shinozaki T
Hinyokika Kiyo; 1995 Oct; 41(10):767-70. PubMed ID: 8533671
[TBL] [Abstract][Full Text] [Related]
20. Editorial comment on: reassessing the diagnostic yield of saturation biopsy of the prostate.
Philip J
Eur Urol; 2008 May; 53(5):981-2. PubMed ID: 17997013
[No Abstract] [Full Text] [Related]
[Next] [New Search]
